首页> 外文期刊>BMC Anesthesiology >Should we restrict erythrocyte transfusion in early goal directed protocols?
【24h】

Should we restrict erythrocyte transfusion in early goal directed protocols?

机译:我们应该在早期目标指导方案中限制红细胞输注吗?

获取原文
           

摘要

Background Early goal-directed therapy has been endorsed in the guidelines of the Surviving Sepsis Campaign as a key strategy among patients presenting with severe sepsis or septic shock. But more importantly, early goal-directed therapy also became standard care for non-septic critically ill patients and was adopted for high-risk surgical patients. Discussion Importantly, transfusion of red blood cells is a central part of many protocols of early goal-directed therapy to indicate the need for use of inotropes and red blood cells, as both central venous saturation and hematocrit are used as transfusion triggers. However, burgeoning data has strongly linked transfusion with worse clinical outcomes. If correct, could these early goal-directed therapy ?bundles’ have better outcome if a restrictive transfusion practice is adopted? Summary Early goal-directed therapy has evolved as standard care for most of critically ill patients, and many protocols contain transfusion of red blood cells targeting high hemoglobin level as a key element. As red blood cell transfusions are associated with increased morbidity and mortality, transfusion thresholds need to be more individualized.
机译:背景技术在脓毒症幸存运动中,早期目标导向疗法已被批准为严重脓毒症或败血性休克患者的关键策略。但更重要的是,早期的针对目标的治疗也已成为非脓毒症危重患者的标准护理,并被高危手术患者采用。讨论重要的是,输血是早期目标导向治疗的许多方案的核心部分,表明需要使用正性肌力药和红细胞,因为中心静脉饱和和血细胞比容均被用作输血触发物。但是,新兴数据已将输血与较差的临床结局紧密联系在一起。如果正确的话,如果采用限制性输血方法,这些早期的针对目标的治疗“束”能否有更好的疗效?总结早期的针对目标的治疗已经发展成为大多数重症患者的标准治疗方法,许多方案都包含针对高血红蛋白水平的红细胞输血作为关键要素。由于红细胞输血会增加发病率和死亡率,因此需要更加个性化地确定输血阈值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号